Bristol-Myers Squibb
Bringing Patient Centricity to Life Whitepaper
Pages
2
Time to read
5 mins
Publication
Language
English
Pages
2
Time to read
5 mins
Publication
Language
English
The document is a whitepaper that focuses on enhancing patient centricity within the Australian healthcare system. It outlines the importance of prioritizing patients' values, preferences, and outcomes in the delivery of healthcare and medicines. The whitepaper discusses the current opportunities for stakeholders, including patients, to engage with the Australian health system and government on reform initiatives. It references the 2021 Parliamentary Inquiry into drug approval processes and the strategic agreement between the Commonwealth and the medicines industry aimed at improving consumer engagement. The whitepaper makes recommendations for broad-scale system reform and practical steps for improving healthcare practices and processes. It emphasizes the need for effective consumer engagement, broader value considerations in Health Technology Assessment (HTA) decision-making, and faster access to medicines. The document aims to empower consumers and enhance their involvement in the healthcare decision-making process, promoting equity and responsiveness in the system.